2022 ICD-10-CM Code D40.10
Neoplasm of uncertain behavior of unspecified testis
Valid for Submission
| ICD-10: | D40.10 |
| Short Description: | Neoplasm of uncertain behavior of unspecified testis |
| Long Description: | Neoplasm of uncertain behavior of unspecified testis |
Code Classification
D40.10 is a billable diagnosis code used to specify a medical diagnosis of neoplasm of uncertain behavior of unspecified testis. The code D40.10 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D40.10 might also be used to specify conditions or terms like leydig cell neoplasm of testis, neoplasm of uncertain behavior of testicular sex cord, neoplasm of uncertain behavior of testis, neoplasm of uncertain behavior of undescended testis, neoplasm of undescended testis , sertoli cell tumor of testis, etc.
The code D40.10 is applicable to male patients only. It is clinically and virtually impossible to use this code on a non-male patient.
Unspecified diagnosis codes like D40.10 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D40.10 are found in the index:
- - Androblastoma
- - unspecified site
- - male - D40.10
- - unspecified site
- - Arrhenoblastoma
- - unspecified site
- - male - D40.10
- - unspecified site
- - Gonadoblastoma
- - unspecified site
- - male - D40.10
- - unspecified site
- - Gonocytoma
- - unspecified site
- - male - D40.10
- - unspecified site
- - Gynandroblastoma
- - unspecified site
- - male - D40.10
- - unspecified site
- - Tumor - See Also: Neoplasm, unspecified behavior, by site;
- - Leydig cell - See: Neoplasm, uncertain behavior, by site;
- - unspecified site
- - male - D40.10
- - unspecified site
- - testicular - D40.10
- - Leydig cell - See: Neoplasm, uncertain behavior, by site;
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
- Diagnoses for males only - The Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, these edits apply to MALES only .
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Leydig cell neoplasm of testis
- Neoplasm of uncertain behavior of testicular sex cord
- Neoplasm of uncertain behavior of testis
- Neoplasm of uncertain behavior of undescended testis
- Neoplasm of undescended testis
- Sertoli cell tumor of testis
- Sex cord stromal tumor of testis
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code D40.10 is grouped in the following groups for version MS-DRG V39.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2021 through 09/30/2022.
| MS-DRG | MS-DRG Title | MCD | Relative Weight |
|---|---|---|---|
| 715 | OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC | 12 | 2.0189 |
| 716 | OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC | 12 | 1.2765 |
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert D40.10 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code D40.10 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 236.4 - Unc behav neo testis (Approximate Flag)
Information for Patients
Testicular Cancer
Testicles, or testes, make male hormones and sperm. They are two egg-shaped organs inside the scrotum, the loose sac of skin behind the penis. You can get cancer in one or both testicles.
Testicular cancer mainly affects young men between the ages of 20 and 39. It is also more common in men who
- Have had abnormal testicle development
- Have had an undescended testicle
- Have a family history of the cancer
Symptoms include pain, swelling, or lumps in your testicles or groin area. Doctors use a physical exam, lab tests, imaging tests, and a biopsy to diagnose testicular cancer. Most cases can be treated, especially if found early. Treatment options include surgery, radiation, and/or chemotherapy. Regular exams after treatment are important.
Treatments may also cause infertility. If you may want children later on, you should consider sperm banking before treatment.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)